Literature DB >> 12746265

18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.

B B Chin1, R L Wahl.   

Abstract

Positron emission tomography with (18)F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12746265      PMCID： PMC1867761          DOI： 10.1136/gut.52.suppl_4.iv23

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  71 in total

1.  Staging recurrent metastatic colorectal carcinoma with PET.

Authors:  D Delbeke; J V Vitola; M P Sandler; R C Arildsen; T A Powers; J K Wright; W C Chapman; C W Pinson
Journal:  J Nucl Med       Date:  1997-08       Impact factor: 10.057

2.  Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.

Authors:  F L Flanagan; F Dehdashti; B A Siegel; D D Trask; S R Sundaresan; G A Patterson; J D Cooper
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

3.  Improvement in staging of esophageal cancer with the addition of positron emission tomography.

Authors:  M I Block; G A Patterson; R S Sundaresan; M S Bailey; F L Flanagan; F Dehdashti; B A Siegel; J D Cooper
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

4.  Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.

Authors:  J Y Choi; K H Lee; Y M Shim; K S Lee; J J Kim; S E Kim; B T Kim
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

5.  Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.

Authors:  Y Fong; P F Saldinger; T Akhurst; H Macapinlac; H Yeung; R D Finn; A Cohen; N Kemeny; L H Blumgart; S M Larson
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

6.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.

Authors:  M Zimny; R Bares; J Fass; G Adam; U Cremerius; B Dohmen; P Klever; O Sabri; V Schumpelick; U Buell
Journal:  Eur J Nucl Med       Date:  1997-06

7.  Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.

Authors:  D Delbeke; D M Rose; W C Chapman; C W Pinson; J K Wright; R D Beauchamp; Y Shyr; S D Leach
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

8.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

Authors:  H Abdel-Nabi; R J Doerr; D M Lamonica; V R Cronin; P J Galantowicz; G M Carbone; M B Spaulding
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

9.  Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.

Authors:  M A Khan; C S Combs; E M Brunt; V J Lowe; M K Wolverson; H Solomon; B T Collins; A M Di Bisceglie
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

10.  Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography.

Authors:  J G Guillem; J Puig-La Calle; T Akhurst; S Tickoo; L Ruo; B D Minsky; M J Gollub; D S Klimstra; M Mazumdar; P B Paty; H Macapinlac; H Yeung; L Saltz; R D Finn; Y Erdi; J Humm; A M Cohen; S Larson
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585
View more
  6 in total

1.  The role of positron emission tomography in esophageal cancer.

Authors:  Gary Y Yang; Timothy D Wagner; Blair A Jobe; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2008-01

2.  Incidental 18F-FDG uptake in the colon: value of contrast-enhanced CT correlation with colonoscopic findings.

Authors:  Julian Kirchner; Benedikt M Schaarschmidt; Firas Kour; Lino M Sawicki; Ole Martin; Johannes Bode; Stephan Vom Dahl; Verena Keitel; Dieter Häussinger; Christina Antke; Christian Buchbender; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-07       Impact factor: 9.236

Review 3.  PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.

Authors:  Keigo Endo; Noboru Oriuchi; Tetsuya Higuchi; Yasuhiko Iida; Hirofumi Hanaoka; Mitsuyuki Miyakubo; Tomohiro Ishikita; Keiko Koyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

4.  Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer.

Authors:  Ukihide Tateishi; Tetsuo Maeda; Tsuyoshi Morimoto; Mototaka Miyake; Yasuaki Arai; E Edmund Kim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-26       Impact factor: 9.236

5.  Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography.

Authors:  Joo Young Lee; Soon Man Yoon; Jeong Tae Kim; Ki Bae Kim; Mi Jin Kim; Jae Geun Park; Taek-Gu Lee; Sang-Jeon Lee; Sung Soo Koong; Joung-Ho Han; Hee Bok Chae; Seon Mee Park; Sei Jin Youn
Journal:  Intest Res       Date:  2017-04-27

6.  18F-FDG PET imaging for identifying the dynamics of intestinal disease caused by SFTSV infection in a mouse model.

Authors:  Daisuke Hayasaka; Kodai Nishi; Takeshi Fuchigami; Kazuya Shiogama; Takanori Onouchi; Satoshi Shimada; Yutaka Tsutsumi; Kouichi Morita
Journal:  Oncotarget       Date:  2016-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.